Final results from an observational study (plateau) of adult patients treated with romiplostim for primary immune thrombocytopenia (ITP) in routine clinical practice in Germany

Category Primary study
JournalHaematologica
Year 2017
This article has no abstract
Epistemonikos ID: 9f04829b116da84d6e417990a49244776af303bd
First added on: Feb 08, 2025